Peer-reviewedCC BYFrontiers in pharmacology
AI-driven multi-omics biomarkers in precision breast cancer therapeutics: from discovery to clinical translation
4 affiliations
- 1University Hospital , ,
- 2Medical Oncology Department, Hospital Universitario 12 de Octubre , ,
- 3Medical Oncology Unit, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico , ,
- 4Medical Oncology Unit, University Hospital of Cagliari , ,
Related
- Clinical Translation of Artificial Intelligence in Oncology: Real-World Validation, Workflow Integration, and Precision Medicine Applications
- Inflammatory phenotypes in severe pneumonia: clinical evidence to mouse models for precision therapeutics
- Toward Precision Colorectal Cancer Screening: Integrating Clinical Risk Stratification, Molecular Biomarkers, and Artificial Intelligence
- Circulating Biomarkers with Artificial Intelligence for Clinical Risk Assessment and Therapeutic Monitoring: Evidence, Limitations, and Translation
- Metastasis Pattern-Specific Biomarkers and Therapeutic Targets in Gastric Cancer: From Surgical Specimens to Clinical Translation.
BibTeX
@article{stylianakis2026aidriven,
title = {{AI-driven multi-omics biomarkers in precision breast cancer therapeutics: from discovery to clinical translation}},
author = {Dimitrios Stylianakis and Rodrigo Sánchez-Bayona and Nerina Denaro and Cinzia Solinas},
journal = {Frontiers in pharmacology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13659096},
note = {CC BY},
}
RIS
TY - JOUR
TI - AI-driven multi-omics biomarkers in precision breast cancer therapeutics: from discovery to clinical translation
AU - Dimitrios Stylianakis
AU - Rodrigo Sánchez-Bayona
AU - Nerina Denaro
AU - Cinzia Solinas
PY - 2026
DA - 2026/10/16
JO - Frontiers in pharmacology
UR - https://europepmc.org/article/PMC/PMC13659096
SN - 1663-9812
ER -